Clinical Trials Browser

Phase 2 × NIH × Extensive Stage Lung Small Cell Carcinoma × Clear all

NCT04334941 2026-04-13

Testing Maintenance Therapy for Small Cell Lung Cancer in Patients With SLFN11 Positive Biomarker

Phase 2 Active not recruiting

Extensive Stage Lung Small Cell Carcinoma

NCT02899728 2023-10-17

Olaparib, Cediranib Maleate, and Standard Chemotherapy in Treating Patients With Small Cell Lung Cancer

Phase 2 Terminated

9 enrolled 4 charts

Extensive Stage Lung Small Cell Carcinoma